| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3042496 | Clinical Neurology and Neurosurgery | 2006 | 4 Pages |
Abstract
Our observations suggest that IL-10 level may be a useful parameter to identify the patients potentially responding to IFN therapy.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Halina Bartosik-Psujek, Zbigniew Stelmasiak,